Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)

This study has been completed.
Roche Pharma AG
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland Identifier:
First received: February 15, 2011
Last updated: October 18, 2011
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)